Literature DB >> 6611838

Mitral valve prolapse: an assessment of clinical features, associated conditions and prognosis.

D C Beton, S G Brear, J D Edwards, J C Leonard.   

Abstract

One hundred and eighty-two patients (100 females, 82 males) with mitral valve prolapse (MVP) confirmed by echocardiography are described. Their ages range from 12 to 87 years (mean 48 years). The symptoms of breathlessness, pain in the chest and palpitations were analysed. They were associated with left ventricular failure, co-existing ischaemic heart disease and arrhythmias in some, but in a proportion the symptoms were thought to be due to psychoneurosis. Seventy-two patients (40 per cent) were referred because of complications of MVP. In 67 patients (37 per cent) the condition was discovered by chance and in 43 patients (24 per cent) neurotic symptoms had led to referral to hospital. A systolic click was heard in 117 patients (54 per cent); 41 patients (23 per cent) had a late systolic murmur and 30 patients (16 per cent) had a pansystolic murmur. The incidence of murmurs rose with increasing age, and pansystolic murmurs were more frequent in males. Thirty-two patients (18 per cent) had neither a click nor a murmur. Twenty-four patients (13 per cent) had associated supraventricular tachycardia and 22 (12 per cent) atrial fibrillation. Twelve patients (7 per cent) had severe mitral incompetence and eight (4 per cent) developed bacterial endocarditis. Only three patients had symptoms suggesting cerebral ischaemia. Twelve patients (7 per cent) had associated aortic incompetence. Twenty-two patients had had an inguinal hernia, the incidence in males over 50 being 26 per cent. Twenty-six patients (14 per cent) had non-specific T wave changes in the electrocardiogram. Echocardiography showed that 112 patients (62 per cent) had mid-systolic buckling of the posterior leaflet and 70 patients (38 per cent) had holosystolic prolapse. In view of the high incidence of complications it is felt that the long-term prognosis not as good as has been generally believed.

Entities:  

Mesh:

Year:  1983        PMID: 6611838

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

1.  Surgical considerations in infective endocarditis.

Authors:  D A Cooley
Journal:  Tex Heart Inst J       Date:  1989

2.  Internal carotid artery occlusion in a young female with mitral valve prolapse.

Authors:  M A Saadah; R A Shakir; M A Rudwan; N Khan
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

Review 3.  Mitral valve prolapse associated with other disorders. Casual coincidence, common link, or fundamental genetic disturbance?

Authors:  A D Malcolm
Journal:  Br Heart J       Date:  1985-04

4.  Mitral valve prolapse: harbinger of death or variant of normal?

Authors:  C M Oakley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

5.  The medicalization of normal variants: the case of mitral valve prolapse.

Authors:  T E Quill; M Lipkin; P Greenland
Journal:  J Gen Intern Med       Date:  1988 May-Jun       Impact factor: 5.128

6.  Age and the clinical profile of idiopathic mitral valve prolapse.

Authors:  A J Hickey; D E Wilcken
Journal:  Br Heart J       Date:  1986-06

7.  A Study of Clinical, Microbiological, and Echocardiographic Profile of Patients of Infective Endocarditis.

Authors:  Soumik Ghosh; Ratnakar Sahoo; Ranjit Kumar Nath; Nandini Duggal; Adesh Kumar Gadpayle
Journal:  Int Sch Res Notices       Date:  2014-11-04

8.  Postural instability revealing infective endocarditis secondary to severe mitral stenosis: A case report with literature review.

Authors:  Raid Faraj; Zaineb Bourouhou; Houda Belhoussine; Asmae Bouamoud; Hasna Rami; Mohamed Cherti
Journal:  Ann Med Surg (Lond)       Date:  2021-12-02

9.  Women with maternal near-miss in the intensive care unit in Yangzhou, China: a 5-year retrospective study.

Authors:  Ying Chen; Jiaoyang Shi; Yuting Zhu; Xiang Kong; Yang Lu; Yanru Chu; Miskatul Mustafa Mishu
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-19       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.